EMERALD MUTUAL FUND ADVISERS TRUST
Q3 2026 Form 13-F

LEOLA, PENNSYLVANIA
CIK 0001352895 · CRD 135130 · SEC-registered investment adviser
$2.5B Reported Value Total

EMERALD MUTUAL FUND ADVISERS TRUST reports 5 total accounts under management (AUM). There are 5 discretionary accounts valued at $2,087,155,055, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Source: Form ADV filed 2026-03-30
Reported value
$2.5B
Quarter over quarter
-13.9%
Holdings
184
Top-10 concentration
19.0%

Key People

Form ADV owners & control persons
John Thomas Hailer
MEMBER/MANAGER
James Andrew Meehan
CHIEF COMPLIANCE OFFICER
Kenneth George Mertz
PRESIDENT, CHIEF INVESTMENT OFFICER AND PORTFOLIO MANAGER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2026 13F record

Q3 2026 13F filing summary

Q3 2026 Form 13F portfolio summary
Period of report September 30, 2026
Filed November 09, 2026
Form 13F-HR
Reported value $2.5B
Positions 184
Change in reported value -13.8%
New positions 17
Exited positions 30
Position turnover 22.0%
Top-10 concentration 19.0%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 9, 2026
184 $2.5B
Q2 2026 13F
Filed Aug 5, 2026
197 $2.8B
Q1 2026 13F
Filed May 4, 2026
199 $2.1B
Q4 2025 13F
Filed Feb 9, 2026
189 $2.1B
Q3 2025 13F
Filed Oct 30, 2025
219 $1.9B
Q2 2025 13F
Filed Aug 4, 2025
212 $1.6B
Q1 2025 13F
Filed May 1, 2025
209 $1.4B
Q4 2024 13F
Filed Feb 14, 2025
212 $1.6B
Q3 2024 13F
Filed Oct 29, 2024
225 $1.9B
Q2 2024 13F
Filed Aug 6, 2024
223 $1.9B
Q1 2024 13F
Filed May 8, 2024
229 $1.9B
Q4 2023 13F
Filed Feb 5, 2024
240 $1.9B
Q3 2023 13F
Filed Oct 27, 2023
236 $1.7B
Q2 2023 13F
Filed Aug 10, 2023
237 $1.8B
Q1 2023 13F
Filed May 4, 2023
217 $1.7B
Q4 2022 13F
Filed Feb 3, 2023
219 $1.6B
Q3 2022 13F
Filed Oct 25, 2022
214 $1.6B
Q2 2022 13F
Filed Jul 29, 2022
211 $1.7B
Q1 2022 13F
Filed Apr 29, 2022
208 $2.3B
Q4 2021 13F
Filed Feb 2, 2022
216 $2.8B

34 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q3 2026

Largest Q3 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 LFSC RBB FD INC $89.0M 3.63%
2 TVTX TRAVERE THERAPEUTICS INC $58.0M 2.36%
3 CORT CORCEPT THERAPEUTICS INC $54.6M 2.23%
4 IDCC INTERDIGITAL INC PA COM $48.1M 1.96%
5 SXT SENSIENT TECHNOLOGIES CORP $40.1M 1.64%
6 COHU COHU INC $37.1M 1.51%
7 PLXS PLEXUS CORP $35.5M 1.45%
8 COGT COGENT BIOSCIENCES INC $34.8M 1.42%
9 MRCY MERCURY SYSTEMS INC $34.4M 1.4%
10 AIR AAR CORPORATION $34.2M 1.4%
11 SMTC SEMTECH CORP $33.9M 1.38%
12 VSEC VSE CORPORATION $33.6M 1.37%
13 GH GUARDANT HEALTH INC $33.3M 1.36%
14 CECO CECO ENVIRONMENTAL CORP $33.1M 1.35%
15 AX AXOS FINANCIAL INC $33.0M 1.35%
16 KLIC KULICKE AND SOFFA INDUSTRIES $32.9M 1.34%
17 LIVN LIVANOVA PLC $32.9M 1.34%
18 SYRE SPYRE THERAPEUTICS $32.6M 1.33%
19 VRNS VARONIS SYSTEMS INC $32.6M 1.33%
20 ESE ESCO TECHNOLOGIES INC $32.5M 1.33%

Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Similar Managers

Finding Similar Managers

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings